Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas

NCT01898078

Conditions: Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: The Bronx, New York, United States

Nashville, Tennessee, United States

San Antonio, Texas, United States

View Trial Details

Completed

The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma

NCT03973164

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Affiliated Tumor Hospital，Guangxi Medical University Nanning, China

View Trial Details

Completed

The CAROLE (CArdiac Related Oncologic Late Effects) Study

NCT03235427

Conditions: Adenocarcinoma, Arterial Occlusive Diseases, Arteriosclerosis, +45 more
Locations: Northwell Health Lake Success, New York, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

NCT00003280

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Kantonspital Aarau Aarau, Switzerland

Office of Walter Weber-Stadelman Basel, Switzerland

University Hospital Basel, Switzerland

Ospedale San Giovanni Bellinzona, Switzerland

View Trial Details

Completed

Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients With Aggressive B-Cell Lymphoma

NCT00987493

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Kantonsspital Baden Baden, Switzerland

Universitaetsspital Basel Basel, Switzerland

St. Claraspital AG Basel, Switzerland

Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland

View all 16 locations

View Trial Details

Completed

Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma

NCT00227695

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Clinical Center - Institute of Hematology São Paulo, Brazil

Istituto Europeo di Oncologia IEO Milan, Italy

Clinical Center Skopje Skopje, North Macedonia

Clinical Center of Serbia Belgrade, Serbia

View all 26 locations

View Trial Details

Completed

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

NCT01164709

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Congenital Abnormalities, +42 more
Locations: Inselspital Bern Bern, Switzerland

Kantonsspital Graubuenden Chur, Switzerland

Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland

Kantonsspital - St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00392691

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations: Kantonsspital Aarau Aarau, Switzerland

Saint Claraspital AG Basel, Switzerland

Universitaetsspital-Basel Basel, Switzerland

Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland

View Trial Details

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma

NCT01962532

Conditions: Adenocarcinoma, Carcinoma, Esophagogastric Junction, +9 more
Locations: Kashiwa, Japan

Matsuyama, Japan

Tokyo, Japan

View Trial Details

Completed

PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

NCT00544219

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: European Institute of Oncology Milan, Italy

Hirslanden Klinik Aarau Aarau, Switzerland

Kantonspital Aarau Aarau, Switzerland

Kantonsspital Baden Baden, Switzerland

View all 19 locations

View Trial Details